Laryngeal Cancer
📧 Sign up to get email alerts when something new happens for Laryngeal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
Phase 2/3 trial evaluating atezolizumab and/or bevacizumab with or without standard chemotherapy as second-line treatment for advanced head …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Biospecimen Procurement for Head and Neck Disorders
This NCI-sponsored clinical trial update describes ongoing biospecimen procurement for head and neck disorders and indicates the study is cu…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma [Phase 3]
A Phase 3 clinical trial evaluating lymphocyte-sparing radio-immunotherapy for head and neck cancers is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer [Phase 2]
This Phase 2 clinical trial is evaluating BMX-001 as a radioprotector added to standard chemoradiation therapy for head and neck cancers and…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: Quality of Life and Functional Outcomes in Laryngeal Cancer Patients
A clinical trial evaluating quality of life, voice quality, swallowing function, and other functional outcomes in patients with laryngeal ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of Vebectotamab Vedotin with Pucotelimab for locally advanced laryngeal cancer, curren…
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Machine Learning-Based Risk Prediction Model for Head and Neck Cancerous Lesions
This clinical trial update describes a machine learning-based risk prediction model for head and neck cancerous lesions, with recruitment no…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer [Phase 1]
This clinical trial update describes a Phase 1 study of stereotactic hypofractionated radioablation (HYDRA) treatment for laryngeal cancer, …
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
This clinical trial update describes the use of blood tests and questionnaires to study adherence to preventative swallowing exercises in pa…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer [Phase 2]
A Phase 2 clinical trial is testing adding chemotherapy or chemo-immunotherapy to standard surgery for advanced head and neck cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin [Phase 1]
Phase 1 trial evaluating the addition of M3814 (peposertib), a DNA-PK inhibitor, to radiation therapy in patients with advanced head and nec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers [Phase 2, Phase 3]
This clinical trial update describes a Phase 2/Phase 3 study evaluating atezolizumab and/or bevacizumab with or without standard chemotherap…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study [Phase 2]
This document reports a Phase 2 clinical trial called HEADLIGHT evaluating intensity-modulated proton therapy or conventional X-ray therapy …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin [Phase 3]
Phase 3 clinical trial update on radiation plus cetuximab versus radiation plus non-cisplatin chemotherapy for head and neck cancer patients…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Role of the Immune System in Preventing Laryngeal Cancer
A recruiting clinical trial is investigating how the immune system might prevent laryngeal cancer, within the broader category of head and n…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Workshops and Exchange Groups for Laryngectomized Patients
A recruiting clinical trial in Paris offers workshops and peer-exchange groups for patients who have undergone laryngectomy, with laryngeal …
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: Phonatory Movement of the Pharyngoesophageal Mucosa in Laryngectomy Patients
This ClinicalTrials.gov update reports that the study evaluating phonatory movement of the pharyngoesophageal mucosa in laryngectomy patient…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer [Phase 1]
Phase 1 trial evaluating TMV vaccine therapy alone and with pembrolizumab for recurrent/metastatic head and neck squamous cell carcinoma; cu…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) [Phase 2]
Phase 2 clinical trial evaluating sacituzumab govitecan in combination with cetuximab for head and neck squamous cell cancers is currently r…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC [Phase 2]
Phase 2 neoadjuvant chemoimmunotherapy trial for resectable head and neck squamous cell carcinoma using camrelizumab with paclitaxel and car…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CONFIRM: Magnetic Resonance Guided Radiation Therapy [NA]
ClinicalTrials.gov study CONFIRM is evaluating magnetic resonance guided radiation therapy and is currently recruiting for several cancers, …
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer [NA]
Clinical trial update for MRI-guided stereotactic ablative radiotherapy (MRI-SABR) in early-stage glottic laryngeal cancer; the study is cur…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma [Phase 2]
A Phase 2 clinical trial evaluating metformin hydrochloride in combination with doxycycline for head and neck squamous cell carcinoma has be…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Post-operative Use of New Adhesive After Total Laryngectomy [NA]
A clinical trial is evaluating a new adhesive for postoperative use after total laryngectomy, and the study is currently not recruiting.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: AI System for Anatomic Recognition & Lesion Detection in Nasopharyngolaryngoscopy: A Prospective Study
This clinical trial update describes a prospective study to evaluate an AI system for anatomic recognition and lesion detection during nasop…